跳至主要内容
临床试验/NL-OMON48776
NL-OMON48776已完成不适用

The effect of consecutive fecal microbiota transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) - a randomized-controlled trial - - NAFLD and Fecal microbiota Transplantation (the NAFTx study)

eids Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Obese (BMI > 27 kg/m2)
  • - Males and postmenopausal females
  • - Aged 18 to 70 years
  • - Hepatic steatosis defined as increased hyperechogenicity of the liver on
  • abdominal ultrasound and/or histological signs of steatosis
  • - Written informed consent

排除标准

  • - Exclusion criteria for MRI (claustrophobia, pacemaker, metal implants, etc)
  • - Any other liver disease than NAFLD/NASH
  • - Present excessive alcohol use defined as > 2 units/day
  • - Recent use (< 3 months) of antibiotics
  • - use of possible drugs interfering microbiota or recent (< 3 months) changes
  • - Recent (< 3 months) weight change (>5%)
  • - Cardiovascular co-morbidity defined as heart failure, coronary insufficiency
  • and hypertension in past history
  • - Previous use of glucocorticosteroids, hormonal substitution, pagitaxel,
  • theofyllin, amiodarone, myelosuppresive agents.
  • - A psychiatric, addictive or any other disorder that compromises the subjects
  • ability to understand the study content and to give written informed consent
  • for participation in the study

研究者

相似试验

The effect of consecutive fecal microbiota... | 临床试验